Nalmefene HCl Crystallization via Azeotropic Solvent Removal
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing Nalmefene Hydrochloride (HCl) often result in crystalline forms that are hygroscopic and contain residual solvents trapped in the crystalline lattice, making it difficult to remove them and potentially unsafe for consumption or non-compliant with regulatory requirements.
Innovation Solution
A method involving the selection of specific organic solvents with varying molar volumes to form azeotropes with water, allowing for controlled solvent removal through vacuum distillation, which produces crystalline Nalmefene HCl with reduced residual solvent content, specifically targeting less than 15 weight % and achieving polymorphs like dihydrate or monohydrate forms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional crystallization methods are used to produce Nalmefene HCl, then the crystalline form can be obtained, but residual solvents become trapped in the crystalline lattice making them difficult to remove
Solution Approach 1:
The patent applies parameter changes by carefully controlling crystallization conditions including temperature, pH, and solvent composition to produce a crystalline form with a less dense lattice structure that does not trap residual solvents, thereby resolving the contradiction between obtaining crystalline form and preventing solvent entrapment
Solution Approach 2:
The patent employs extraction by treating the crystalline Nalmefene HCl with a solvent that selectively removes residual solvents from the crystal lattice without dissolving the active ingredient, thereby extracting the harmful residual solvents while preserving the crystalline structure
2Manufacturing precision
If the monohydrate form of Nalmefene HCl is produced, then crystallization is achieved, but the product becomes hygroscopic which complicates storage and handling
Solution Approach 1:
The patent changes the crystallization parameters including temperature, pH, and solvent system to promote formation of the dihydrate form instead of the monohydrate form, thereby obtaining a crystalline product that is not hygroscopic and has improved storage stability
Solution Approach 2:
The patent achieves local quality by creating a specific crystal structure with defined water of crystallization (dihydrate form) that has different physical properties including non-hygroscopicity, thereby improving reliability while maintaining crystallization benefits
3Productivity
If organic solvents are used in the synthesis of Nalmefene HCl, then the reaction proceeds efficiently, but the solvents become entrapped in the crystalline lattice and are difficult to remove
Solution Approach 1:
The patent employs extraction by treating the crystalline product with appropriate solvents that selectively remove residual organic solvents from the crystal lattice while leaving the Nalmefene HCl intact, thereby eliminating the harmful residual solvent content
Solution Approach 2:
The patent uses intermediary substances or solvent systems that facilitate the removal of residual organic solvents from the crystal lattice, acting as mediators that enable efficient solvent exchange or displacement without affecting the active ingredient
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method effectively reduces residual solvent content in Nalmefene HCl to desirable levels, ensuring safety and compliance, and allows for the production of non-hygroscopic dihydrate forms, enhancing the crystallization process efficiency and yield.
Implementation Method 1
selection of specific organic solvents with varying molar volumes to form azeotropes with water
Implementation Method 2
allowing for controlled solvent removal through vacuum distillation
Implementation Method 3
allows for the production of non-hygroscopic dihydrate forms, enhancing the crystallization process efficiency and yield
Data Source
AI summary
Methods for removing residual solvent from Nalmefene Hydrochloride (HCl) and producing crystalline Nalmefene HCl monohydrate, monosolvate or crystalline Nalmefene HCl dihydrate are described. In embodiments, the methods include recrystallizing Nalmefene HCl from a solvate that includes Nalmefene HCl, water, and a first solvent, wherein the first solvent has a molar volume of at least 98 cm3. Crystalline Nalmefene HCl with a desirably low amount of residual solvent is also described.